Navigation Links
PQ Bypass Graduates from the Fogarty Institute for Innovation, Establishes Independent Operations

MOUNTAIN VIEW, Calif., Dec. 6, 2012 /PRNewswire/ -- The Fogarty Institute for Innovation proudly announced today that PQ Bypass, a resident of the Institute and participant in its Innovator Support Program, has received its Series A financing and will be establishing independent operations in Sunnyvale, Calif., as of January 1, 2013, effectively 'graduating' from the program.   

"The goal of the Innovator Support Program is to provide companies like PQ Bypass with access to the physical and intellectual resources that will enable them to cultivate their innovations faster and ultimately reach patients," said Frederick St. Goar, M.D., F.A.C.C., Board member of the Fogarty Institute.   "We congratulate PQ Bypass for securing their Series A financing and wish them continued success as they forge ahead." 

PQ Bypass has developed a percutaneous approach to achieving a long-lasting, robust bypass in the femoral artery with results that are comparable to surgical bypass, but without the patient morbidity or hospital stay costs.

"Our experience at the Fogarty Institute was second to none; we are beyond grateful for the support we received over these last 2 years," said Richard A. Lotti, president and CEO, PQ Bypass.  "We are energized to enter this next stage of our Company's development and would encourage other companies or individuals to consider participating in this program."

For early stage (pre-A-round) medical innovators seeking to participate in the Innovator Support Program, the Institute is currently accepting applications.  Selected innovators will house their nascent companies at the Fogarty Institute in Mountain View, CA and will have access to physician and business mentoring, clinical access, laboratory/office space, and financial aid.  They will have access to clinical experience and clinical trial management services available through El Camino Hospital and the Institute's Taft Center for Clinical Research.  

Eligibility criteria include:

  • Unfunded or modestly funded innovators who need support building the technical and/or business validation needed to attract an initial round of financing (typically an "A-round")
  • Individuals or small teams
  • Innovators who, while they are working on their idea with the support of the Fogarty Institute, are able to work at the Fogarty Institute facility in Mountain View, CA
  • Innovators who will significantly benefit from the unique educational resources (e.g. mentoring and clinical access) provided by the Institute
  • Innovators whose ideas address a major unmet clinical need, or provide an opportunity to significantly improve an existing treatment method

Applications for the Innovator Support Program are due January 9, 2013, and an application and instructions can be found online at:

About The Fogarty Institute for Innovation
The Fogarty Institute for Innovation is 501(c)3 educational  non-profit organization that serves to improve patient care by supporting medical  innovation. Its educational activities involve teaching the skills and methodology necessary for medical innovators to translate their ideas into new patient therapies. The Institute and its affiliated Taft Center for Clinical Research are located on the campus of El Camino Hospital in Mountain View, Calif. To learn more about our organization, visit

About El Camino Hospital
El Camino Hospital is an acute-care, 443-bed, not-for-profit and locally governed organization with campuses in Mountain View and Los Gatos, Calif.  In addition to state-of-the-art emergency departments, key medical specialties include heart and vascular, cancer care, urology, orthopedic and spine, neuroscience, genomic medicine, and the only Women's Hospital in Northern California.  The hospital is recognized as a national leader in the use of health information technology and wireless communications, and has been awarded the Gold Seal of Approval from The Joint Commission as a Primary Stroke Center as well as back-to-back ANCC Magnet Recognitions for Nursing Care.  To learn more, visit the El Camino Hospital website, find them on Facebook, follow them on Twitter, or view videos on YouTube. For a physician referral, visit the website or call the El Camino Health Line at 800-216-5556.

SOURCE El Camino Hospital
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Spiral Flow[TM] Grafts Offer Superior Clinical Outcomes in Prosthetic Bypass Grafting
2. Medical Sales College Boasts An 81.99% Placement Rate For 2011 Graduates
3. Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
4. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Honored Dr. Thomas Fogarty with the 2012 Lifetime Achievement Award
5. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
6. Midwest Orthopaedics at Rush Minimally Invasive Spine Institute Opens Today
7. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
8. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
9. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
10. Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis
11. The Rogosin Institute and Hebrew Home Collaborate to Provide New Dialysis Service for Residents and Patients
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... On November 25, 2015, officials of Narconon Arrowhead ... the release of a new cutting edge recovery program that has been 50 years ... drug- and alcohol-addicted individuals with the purpose to free addicts from the symptoms and ...
(Date:11/25/2015)... ... ... The McHenry County law firm of Botto Gilbert Lancaster, PC ... Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant David Adcock ... , According to court documents, Adcock testified that on May 10, 2010 he sat ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is pleased to ... facial wrinkling. While many patients are aware of the benefits of Botox® in the ... to those suffering with discomfort, soreness, and pain as a result of Jaw Tension, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android app ... new app features a more intuitive SleepScore™ that rates sleep quality on a 100-point ... SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide an ...
(Date:11/25/2015)... , ... November 25, 2015 , ... In an ongoing ... Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its ... surgical intensive care units (totaling 30 beds) from May 2014 through October 2015 at ...
Breaking Medicine News(10 mins):